UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 620,555,381 | 1,109,343 | SH | SOLE | 1,109,343 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 89,527 | 73,383 | SH | SOLE | 73,383 | 0 | 0 | ||
| SURROZEN INC | COM | 86889P208 | 558,864 | 47,930 | SH | SOLE | 47,930 | 0 | 0 | ||
| SURROZEN INC | *W EXP 08/01/2 | 86889P117 | 1,000 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 166,342 | 291,828 | SH | SOLE | 291,828 | 0 | 0 | ||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 343,492 | 192,973 | SH | SOLE | 192,973 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 65,991 | 91,910 | SH | SOLE | 91,910 | 0 | 0 | ||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 180,736 | 249,635 | SH | SOLE | 249,635 | 0 | 0 | ||
| Q32 BIO INC | COM | 746964105 | 220,940 | 133,903 | SH | SOLE | 133,903 | 0 | 0 | ||
| NU HLDGS LTD | ORD SHS CL A | G6683N103 | 9,317,683 | 909,930 | SH | SOLE | 909,930 | 0 | 0 | ||